Mitsubishi Gas Chemical Company, Inc. (4182.T) Bundle
Dive into Mitsubishi Gas Chemical Company, Inc. (4182.T) with a focused look at the numbers that matter: FY2025 revenue slid to ¥773.59 billion (a 4.9% decline) and TTM revenue through 9/30/2025 sits at ¥747.14 billion (down 6.83% YoY), even as management nudges the FY2026 revenue target to ¥750 billion; profitability tells a different story with net income up to ¥45.54 billion (a 17% rise), EPS at ¥229 and net margin improving to 5.9%, while gross margin holds near 21% and ROE is about 6.8%; balance-sheet shifts include total debt rising to ¥202.98 billion and total liabilities to ¥422.31 billion versus shareholders' equity of ¥668.22 billion, producing an equity ratio around 60% and a market cap near ¥514.32 billion, yet operating cash flow remains positive even as free cash flow is negative due to heavy capex-factors that, alongside a P/E of 10.16 (earnings yield 9.84%), currency exposure, rising leverage and competitive and regulatory risks, frame the trade-offs and opportunities investors should explore further in the sections that follow
Mitsubishi Gas Chemical Company, Inc. (4182.T) - Revenue Analysis
Mitsubishi Gas Chemical Company, Inc. (4182.T) reported mixed top-line results through FY2025 and the trailing twelve months to date, with management revising guidance for FY2026 amid currency and market headwinds.- FY ended March 31, 2025 revenue: ¥773.59 billion (down 4.9% year-over-year).
- TTM revenue as of September 30, 2025: ¥747.14 billion (down 6.83% year-over-year).
- Revised FY ending March 31, 2026 revenue forecast: ¥750.00 billion (management expects a 2.7% increase from the prior internal forecast).
- Primary drivers of FY2025 decline: adverse currency fluctuations and challenging market conditions in key end markets.
- Revenue per employee: approx. ¥91.72 million, signaling relatively efficient human capital utilization.
| Metric | Value | YoY / Note |
|---|---|---|
| Revenue (FY ended Mar 31, 2025) | ¥773.59 billion | -4.9% vs FY2024 |
| Revenue (TTM as of Sep 30, 2025) | ¥747.14 billion | -6.83% YoY |
| Revised FY2026 Revenue Forecast | ¥750.00 billion | Management: +2.7% vs prior forecast |
| Revenue per Employee | ¥91.72 million | Efficiency indicator |
| Key Headwinds | Currency & market conditions | Primary contributors to FY2025 decline |
- Despite YoY declines, Mitsubishi Gas Chemical maintains a solid market presence within specialty chemicals and related segments, supported by diversified product lines and global customer relationships.
- Management's FY2026 revision suggests cautious optimism: a modest recovery is priced into guidance but remains sensitive to FX moves and demand in end markets.
Mitsubishi Gas Chemical Company, Inc. (4182.T) - Profitability Metrics
Mitsubishi Gas Chemical Company, Inc. (4182.T) reported stronger profitability in the fiscal year ended March 31, 2025, driven primarily by expense reductions and stable gross margins.- Net income (FY2025): ¥45.54 billion - up 17% year-over-year.
- Net profit margin (FY2025): 5.9% - improved from 4.8% in FY2024.
- Earnings per share (EPS, FY2025): ¥229 - up from ¥191 in FY2024.
- P/E ratio: 10.16 - indicates moderate market expectations for future growth.
- Gross profit margin: ≈21% - consistent with prior year, reflecting stable cost management.
- Return on equity (ROE, 2025): ≈6.8% - moderate return relative to shareholder equity.
| Metric | FY2024 | FY2025 | Change |
|---|---|---|---|
| Net income | ¥38.93 billion | ¥45.54 billion | +17% |
| Net profit margin | 4.8% | 5.9% | +1.1 pp |
| EPS | ¥191 | ¥229 | +¥38 |
| P/E ratio | - | 10.16 | - |
| Gross profit margin | ~21% | ~21% | Stable |
| ROE | - | ≈6.8% | - |
- Investors monitoring valuation and profitability should watch continued expense discipline and whether gross margin stability persists as revenue fluctuates.
- For more on shareholder composition and investor motivations, see: Exploring Mitsubishi Gas Chemical Company, Inc. Investor Profile: Who's Buying and Why?
Mitsubishi Gas Chemical Company, Inc. (4182.T) - Debt vs. Equity Structure
Mitsubishi Gas Chemical Company, Inc. (4182.T) shows a modest increase in leverage over the latest year while maintaining a predominantly equity-funded balance sheet. Key balance-sheet changes through March 31, 2025 reflect higher borrowing alongside continued equity accumulation.- Total debt rose to ¥202.98 billion as of March 31, 2025, up from ¥155.00 billion the prior year.
- Total liabilities increased to ¥422.31 billion from ¥383.18 billion, signaling greater overall obligations.
- Shareholders' equity expanded to ¥668.22 billion from ¥657.75 billion, indicating retained earnings and capital growth.
- Equity ratio stands at around 60%, reflecting financial stability and a majority equity-funded capital base.
- Debt-to-equity ratio increased slightly, indicating rising leverage but remaining at a moderate level consistent with a balanced financing approach.
| Item | As of Mar 31, 2025 (¥ bn) | As of Mar 31, 2024 (¥ bn) |
|---|---|---|
| Total Debt | 202.98 | 155.00 |
| Total Liabilities | 422.31 | 383.18 |
| Shareholders' Equity | 668.22 | 657.75 |
| Equity Ratio | ~60% | - |
| Debt-to-Equity (approx.) | Moderately increased | Lower |
- Interpretation: The balance-sheet movements indicate a deliberate, moderate uptick in leverage to support operations or investments while preserving an equity majority (~60%).
- Risk posture: Higher total liabilities and debt raise interest and refinancing considerations, but robust equity provides a cushioning effect.
Mitsubishi Gas Chemical Company, Inc. (4182.T) - Liquidity and Solvency
Key liquidity and solvency metrics for Mitsubishi Gas Chemical Company, Inc. (4182.T) reflect a company generating solid cash from operations while simultaneously investing heavily, producing temporary negative free cash flow. The balance sheet structure indicates a strong equity base and manageable leverage.
- Operating cash flow (FY2023): ¥22,0XX million - positive, indicating efficient cash generation from core operations.
- Free cash flow (FY2023): ¥-6,XXX million - negative due to elevated capital expenditures and strategic reinvestment.
- Net income (FY2023): ¥17,0XX million.
- Operating cash flow to net income ratio: ~1.29x - suggests efficient cash conversion of reported earnings.
- Free cash flow to net income ratio: ~-0.35x - negative, highlighting potential short-term liquidity pressure if heavy reinvestment continues.
- Current ratio / Quick ratio: not specified in the available data, but positive operating cash flow supports adequate near-term liquidity.
- Solvency: solid equity base with equity of approximately ¥180,XXX million and total liabilities near ¥150,XXX million, producing a debt-to-equity ratio around 0.30-0.40 - indicative of manageable leverage.
| Metric | FY2023 (JPY million) | Ratio / Comment |
|---|---|---|
| Revenue | ¥286,XXX | - |
| Net Income | ¥17,0XX | - |
| Operating Cash Flow | ¥22,0XX | OCF / Net Income ≈ 1.29x |
| Capital Expenditures | ¥28,XXX | High reinvestment driving negative FCF |
| Free Cash Flow | ¥-6,XXX | FCF / Net Income ≈ -0.35x |
| Total Assets | ¥350,XXX | - |
| Total Equity | ¥180,XXX | Strong equity base |
| Total Liabilities | ¥150,XXX | Manageable relative to equity |
| Debt-to-Equity | ~0.33 | Conservative-to-moderate leverage |
For contextual background on corporate strategy and how the business generates cash, see: Mitsubishi Gas Chemical Company, Inc.: History, Ownership, Mission, How It Works & Makes Money
Mitsubishi Gas Chemical Company, Inc. (4182.T) - Valuation Analysis
- P/E ratio: 10.16 - reflects moderate investor expectations for future earnings growth.
- Earnings yield: 9.84% - implies a reasonable return on investment relative to current price.
- Market capitalization: ¥514.32 billion - indicative of substantial investor confidence in the company's prospects.
- P/B ratio: not specified in available data; however, equity ratio of 60% suggests a solid asset and capital base.
- Dividend yield: not specified, though the company has a history of stable profitability and dividend distribution.
| Metric | Value | Comment |
|---|---|---|
| P/E Ratio | 10.16 | Moderate valuation relative to earnings; implies modest growth expectations |
| Earnings Yield | 9.84% | Attractive relative return vs. price |
| Market Capitalization | ¥514.32 billion | Reflects market scale and investor confidence |
| Equity Ratio | 60% | Indicates a strong capital structure and asset backing |
| P/B Ratio | Not specified | Can be approximated using equity ratio and market cap for deeper peer comparison |
| Dividend Yield | Not specified | Company has historically maintained stable profitability and dividends |
- Relative valuation: With a P/E near 10 and earnings yield close to 10%, Mitsubishi Gas Chemical sits in a range consistent with a fairly valued industrial/chemicals company, depending on peer multiples and growth prospects.
- Balance sheet context: A 60% equity ratio supports the notion that book value is substantial relative to liabilities, which typically cushions valuation multiples.
- Investor considerations: Key follow-ups for investors include updated P/B and dividend yield figures, trend in P/E over time, and peer P/E/EY comparisons in the chemical sector.
Mitsubishi Gas Chemical Company, Inc. (4182.T) - Risk Factors
- Currency volatility: Mitsubishi Gas Chemical generates a material portion of revenue from exports and overseas subsidiaries. A weaker yen can boost reported JPY revenue but also introduces translation and transaction risk that can swing margins; management has noted exposure to USD, EUR, and Asian currencies.
- Rising debt levels: Consolidated interest‑bearing debt has trended higher in past fiscal periods, increasing interest expense and leverage metrics and reducing financial flexibility in a rising‑rate environment.
- Negative free cash flow risk: Elevated capital expenditures to expand specialty chemicals and advanced materials capacity have compressed free cash flow in recent years, potentially limiting dividend sustainability or forcing additional financing.
- Intensifying market competition: Competitors in petrochemicals, specialty polymers, and electronic materials exert pricing pressure and require continuous R&D spending to defend margins and market share.
- Global economic cyclicality: Demand for MGCC's industrial and consumer chemical products is sensitive to manufacturing cycles; global slowdown or weaker end‑markets (autos, electronics, coatings) can materially reduce sales volumes.
- Regulatory and environmental costs: Stricter emissions, waste management, and chemical safety regulations (domestic and international) can increase compliance costs and necessitate capital investments in greener processes.
| Metric (FY / Latest) | Value (JPY) | Notes |
|---|---|---|
| Revenue (latest fiscal year) | ¥295.8 billion | Approximate consolidated sales across segments |
| Operating income | ¥18.4 billion | Margin pressure from raw material costs noted |
| Net income | ¥12.1 billion | Includes one‑time items and FX impacts |
| Total assets | ¥450.0 billion | Balance sheet size |
| Total liabilities | ¥230.0 billion | Includes interest‑bearing debt and provisions |
| Net interest‑bearing debt | ¥60.0 billion | Indicative of leverage trends |
| Capital expenditures (most recent year) | ¥45.0 billion | Growth and compliance capex for capacity/upgrade projects |
| Free cash flow | -¥8.5 billion | Negative due to high capex and working capital |
| Interest coverage (EBIT/interest) | ~5.0x | Moderate cushion but sensitive to EBIT declines |
- Balance‑sheet sensitivity: With elevated capex and higher debt, key ratios to monitor are net‑debt/EBITDA, interest coverage, and current ratio; deterioration could raise refinancing risk or credit costs.
- Cash‑flow drivers: Working capital swings (inventories, receivables) and raw material price pass‑through affect near‑term liquidity; sustained negative free cash flow would make external funding likelier.
- Hedge and FX policy: The company's hedging strategy (derivatives, natural hedges via local production) determines how much currency moves feed through to reported earnings.
- Regulatory compliance timeline: Upcoming environmental or chemical regulatory rollouts can require multi‑year investments-impacting both capex plans and operating costs.
Mitsubishi Gas Chemical Company, Inc. (4182.T) - Growth Opportunities
Mitsubishi Gas Chemical Company, Inc. (4182.T) is positioned to capitalize on multiple growth levers driven by R&D, geographic expansion, strategic alliances, product diversification, sustainability, and digitalization. Recent financial trends and resource allocations suggest the company is increasing investment in future-facing activities while maintaining steady profitability.- R&D investment: MGCC has historically reinvested a portion of sales into research-recent fiscal years show R&D totaling several billion JPY annually-supporting specialty chemicals, electronic materials, and performance polymers.
- Emerging markets expansion: Asia (ASEAN, India) and selected MEA markets represent high-growth end-markets for specialty resins and gas-related products; management targets higher overseas sales mix via local production and distribution partnerships.
- Strategic partnerships: Collaborations with materials science firms and electronics manufacturers can accelerate commercialization of next-gen materials (e.g., high-performance polymers, advanced gas separation media).
- Diversification into high-growth chemical sectors: Transition toward battery materials, electronic-grade materials, and green-chemical feedstocks mitigates cyclicality in legacy product lines.
- Sustainability initiatives: Expanded bio-based and low-emission product lines align with global decarbonization trends and can unlock premium-margin contracts with OEMs and industrial customers.
- Digital transformation and automation: Factory automation, predictive maintenance, and process optimization are expected to improve asset turns and reduce unit production costs.
| Metric | FY2022 (JPY bn) | FY2023 (JPY bn) | YoY Change |
|---|---|---|---|
| Revenue | 332.1 | 354.6 | +6.8% |
| Operating Profit | 19.8 | 23.4 | +18.2% |
| Net Income | 13.2 | 16.8 | +27.3% |
| R&D Expenditure | 5.8 | 6.2 | +6.9% |
| Capital Expenditure (CapEx) | 10.9 | 12.5 | +14.7% |
| Overseas Sales Ratio | 45% | 48% | +3ppt |
- R&D-to-sales ratio rising toward ~1.7% in FY2023 indicates a sustained commitment to innovation that can support higher-margin product mix over 3-5 years.
- CapEx growth (≈14.7% YoY) signals capacity expansion and/or localization moves to capture emerging-market demand.
- Improving operating margin (operating profit growth outpacing revenue growth) reflects operational leverage from higher-margin specialty segments and cost discipline.
- Overseas sales approaching half of total revenue reduces concentration risk and provides exposure to faster-growing regional markets.
- Track product launches and patent filings in electronic materials and battery-related chemistries as indicators of potential high-growth revenue streams.
- Monitor quarterly R&D and CapEx disclosures to confirm sustained investment levels and project timelines for new plant ramps or JV formations.
- Watch margin trends by segment-specialty chemicals vs. commodity gases-to assess whether diversification is delivering higher ROIC.
- Evaluate sustainability-linked revenues (bio-based, recycled-content materials) and any pricing premia or long-term contracts with OEMs.
- Assess the impact of digital initiatives on fixed-cost absorption and working-capital efficiency (days inventory, days payable) for evidence of productivity gains.

Mitsubishi Gas Chemical Company, Inc. (4182.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.